Power and sample size calculations for interval-censored survival analysis-Reference-Cited by-同舟云学术

Power and sample size calculations for interval-censored survival analysis

Published:2015-12-07 Issue:8 Volume:35 Page:1390-1400
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Kim Hae-Young¹,Williamson John M.²,Lin Hung-Mo³

Affiliation:

1. Department of Epidemiology and Community Health; New York Medical College; 40 Sunshine Cottage Rd Valhalla NY 10595 U.S.A.

2. Division of Parasitic Diseases and Malaria, National Center of Global Health; Centers for Disease Control and Prevention (MS A-06); 1600 Clifton Road Atlanta GA 30329 U.S.A.

3. Department of Population Health Science and Policy; Ichan School of Medicine at Mount Sinai; One Gustave L. Levy Place New York Box 1010 NY 10029 U.S.A.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6832/fullpdf

Reference40 articles.

1. So Y Johnston G Analyzing interval-censored survival data with SAS software SAS Global Forum SAS Institute, Inc.: Cary, NC, 2010 257 2010

2. Asymptotically effcient rank invariant test procedures;Peto;Journal of the Royal Statistical Society, Series A,1972

3. A proportional hazards model for interval-censored failure time data;Finkelstein;Biometrics,1986

4. A nonparametric test for interval-censored failure time data with application to AIDS studies;Sun;Statistics in Medicine,1996

5. Generalized log-rank test for mixed interval-censored failure time data;Zhao;Statistics in Medicine,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized two-stage optimal design for interval-censored data;Journal of Biopharmaceutical Statistics;2021-12-10

2. Determination of hazard ratio for progression‐free survival considering the tumor assessment schedule in sample size calculation;Pharmaceutical Statistics;2020-02-17

3. Cohort study design for illness-death processes with disease status under intermittent observation;Biostatistics & Epidemiology;2019-01-01

4. Sample size planning of two-arm superiority and noninferiority survival studies with discrete follow-up;Statistics in Medicine;2017-06-12